Abciximab, a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitor mainly …

2025年2月1日 · Abciximab is used to lessen the chance of heart attack in people who need percutaneous coronary intervention (PCI), a procedure to open blocked arteries of the heart. A …

2024年3月8日 · It is used to lower the number of heart attacks in patients who have unstable angina or mild heart attacks. What do I need to tell my doctor BEFORE I take Abciximab? If …

Abciximab is a monoclonal anti-glycoprotein IIb/IIIa receptor antibody used to prevent thrombosis during percutaneous coronary intervention. Abciximab is a Fab fragment of the chimeric …

Abciximab is used to lessen the chance of heart attack in people who need percutaneous coronary intervention (PCI), a procedure to open blocked arteries of the heart. A heart attack …

2023年8月23日 · ReoPro is used to lessen the chance of heart attack in people who need percutaneous coronary intervention (PCI), a procedure to open blocked arteries of the heart. A …

Medscape - Indication-specific dosing for ReoPro, (abciximab), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost...

ABCIXIMAB (ab SIX i mab) prevents blood clots during episodes of chest pain or a heart attack. It may be used during heart surgery.

Abciximab is a prescription medication used for the prevention of unstable angina or cardiac complications in people undergoing PCI.

Abciximab is a medication used to prevent blood clots in patients with certain heart conditions, particularly during procedures like angioplasty. It works by inhibiting platelets, which are blood …